SightfileU.S. market data from official filings
Companies › BMRN
BIOMARIN PHARMACEUTICAL INC (BMRN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001048477 · EDGAR filings · Updated 2026-07-13
BIOMARIN PHARMACEUTICAL INC (BMRN) has reported institutional ownership of 95.0%, with 550 institutional managers holding positions valued at $10.4B per the latest 13F reporting period.
Institutional ownership
95.0%
Institutional managers
550
Reported 13F value
$10.4B
Insider activity
55 trans.
−$3.10M net selling
Latest updates
- 2026-07-13 — Amended current report (8-K/A) filed
- 2026-06-04 — Insider transaction reported (Form 4)
- 2026-06-04 — Insider transaction reported (Form 4)
- 2026-06-04 — Insider transaction reported (Form 4)
- 2026-06-04 — Insider transaction reported (Form 4)
- 2026-06-04 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BIOMARIN PHARMACEUTICAL INC has 550 institutional holders and institutional ownership of 95.0%.
Insider activity
Insiders reported 55 transactions (0 buys, 5 sells) across 18 reporting insiders, with a net reported value of −$3.10M.
Related companies
PENUMBRA INC (PEN) · EXELIXIS INC (EXEL) · ENSIGN GROUP INC (ENSG) · BEONE MEDICINES LTD (ONC) · REVVITY INC (RVTY) · SANOFI SA (SNY)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-13.